News
New AHA guidance targets obesity-related hypertension
Clinicians are addressing the secondary problem (i.e., hypertension or diabetes), but not the root cause of obesity as aggressively, says the...
News
Novel diabetic foot ulcer cream shows promise in phase 3 trial
The first-in-class cream, which acts on macrophages, was better than a standard absorbent dressing for healing diabetic foot ulcers in a phase 3...
News
‘Quadpill’ bests monotherapy for initial BP lowering: QUARTET
The study emphasizes the importance, potential benefits, and simplicity of low-dose BP-lowering drugs combined in one pill, as part of a strategy...
News
Mediterranean diet tied to less severe erectile dysfunction
“The Mediterranean diet could play a role in maintaining several parameters of vascular health and quality of life and in middle-aged men with...
News
FDA approves first once-weekly growth hormone for children
The heiGHt trial demonstrated noninferiority of lonapegsomatropin to somatropin daily injections.
News
‘High normal’ sodium, poor hydration linked to heart failure
Because a high-normal sodium level in midlife may predict future heart failure, patients should monitor hydration and clinicians should not assume...
News
Coffee drinking in midlife tied to heart benefits
A new study found coffee consumption was linked to better heart structure and function, based on cardiac MRI findings and stroke and mortality...
News
Vitamin D pills do not alter kidney function in prediabetes
A subgroup analysis suggests Vitamin D supplements could have a beneficial effect on kidney health.
News
Tackle obesity to drop risk for secondary cardiac event
‘It seems that obesity is not considered by physicians as a serious medical problem, which requires attention’ to lower risk for a secondary...
News
Certain gut bacteria tied to lower risk of diabetes
Greater gut microbial diversity and abundance of 12 types of butyrate-producing bacteria may hinder the development of type 2 diabetes, a...
News
Dapagliflozin safe, protective in advanced kidney disease
“This is now the absolute reassurance that we do not have to stop an SGLT2 inhibitor in people with eGFR< 30 mL/min for safety reasons” and...
News
New agents for youth-onset type 2 diabetes ‘finally in sight’
‘A number of clinical trials of antidiabetic pharmacologic agents in diabetic youth have been completed, demonstrating safety and efficacy, and a...
News
AMPLITUDE-O: Efpeglenatide benefits in high-risk diabetes
In older patients with long-time type 2 diabetes and CVD or kidney disease, the investigational GLP-1 agonist efpeglenatide was safe and lowered...